Objective-To determine 1) the reproducibility of metabolite measurements by 1 H MRS in the motor cortex; 2) the extent to which 1 H MRS imaging (MRSI) detects abnormal concentrations of N-acetylaspartate (NAA)-, choline (Cho)-, and creatine (Cre)-containing compounds in early stages of ALS; and 3) the metabolite changes over time in ALS.Methods-Sixteen patients with definite or probable ALS, 12 with possible or suspected ALS, and 12 healthy controls underwent structural MRI and multislice 1 H MRSI. 1 H MRSI data were coregistered with tissue-segmented MRI data to obtain concentrations of NAA, Cre, and Cho in the left and right motor cortex and in gray matter and white matter of nonmotor regions in the brain.Results-The interclass correlation coefficient of NAA was 0.53 in the motor cortex tissue and 0.83 in nonmotor cortex tissue. When cross-sectional data for patients were compared with those for controls, the NAA/(Cre + Cho) ratio in the motor cortex region was significantly reduced, primarily due to increases in Cre and Cho and a decrease in NAA concentrations. A similar, although not significant, trend of increased Cho and Cre and reduced NAA levels was also observed for patients with possible or suspected ALS. Furthermore, in longitudinal studies, decreases in NAA, Cre, and Cho concentrations were detected in motor cortex but not in nonmotor regions in ALS.Conclusion-Metabolite changes measured by 1 H MRSI may provide a surrogate marker of ALS that can aid detection of early disease and monitor progression and treatment response.ALS is a neurodegenerative disorder that causes rapid loss of motor neurons in the brain and spinal cord leading to paralysis and death. Diagnosis is based solely on clinical data, and there is no definitive diagnostic test for ALS and no surrogate marker for directly measuring disease progression. Therefore, an objective and quantitative method would be extremely helpful to evaluate viability and functioning of upper motor neurons in ALS, identify individuals at an early stage of the disease, and monitor responses to treatment. In addition to NAA, 1 H MRS measures resonances from choline (Cho)-and creatine (Cre)-containing compounds in the brain. Cre represents a combination of creatine and phosphocreatine, a putative marker of gliosis, 3,6 and Cho is thought to be a marker associated with membrane phospholipids. 7In most previous MRS studies of ALS,4,[8][9][10][11][12][13][14][15][16][17][18][19][20] sampling of metabolite signals from the motor cortex was limited, because measurements were restricted to a rectangular region within the brain that was sufficiently distant from the skull to avoid interferences with an intense signal from extracranial lipids. Furthermore, because the selected regions of interest were generally large, including unavoidably some white matter and nonmotor tissue, results from these studies may have been skewed to the extent that white matter and nonmotor regions contributed to the metabolite signal from the motor cortex. With use of a multiplana...